Crescita Therapeutics Inc T.CTX

Alternate Symbol(s): CRRTF

Healthcare Biotechnology

Crescita Therapeutics Inc. is a commercial dermatology company with in-house research and development (R&D) and manufacturing capabilities. It offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. It operates in three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products for the Canadian and international markets. It also commercializes Pliaglis, NCTF Boost 135 HA, ART FILLER, and Obagi Medical in Canada. The Licensing and Royalties segment engaged in licensing the intellectual property related to Pliaglis or its transdermal delivery technologies. Manufacturing and Services segment engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization infrastructure, and product development services.

TSX:CTX - Post by User

Crescita Therapeutics Inc

Bullboard Posts

Comment by TheRock07on Nov 15, 2016 8:49am

196 Views

Post# 25461353

RE:RE:Good Q3 Report --$23.5 million in cash

Operating margins for the partial quarter production of Intega products was 39 %.

As sales expand and costs distributed, operating margins will increase significantly.

As of Sept 50, CTX had $1.70 /share in cash.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal